Home > PRODUCTS > Biological Products

Biological Products

Humanwell focuses on emerging biological products. The company has four products on the market, and one pending CFDA approval. In 2012, Humanwell’s two major biological products, rhG-CSF and rhEPO, delivered 100 million RMB in sales; (increased by 20% and 30%, respectively).

Featured Products:

NAME FORMULATION USAGE AND INDICATION
rhG-CSF Injection Cancer
rh-EPO Injection Anemia by chronic renal failure
Human Immunoglobulin (pH4) for Intravenous Injectable Injection Hives and infectious hepatitis
Human Albumin Injection Injuries and burn